Physicochemical characterization of drug nanocarriers
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Pharmaceutical design has enabled important advances in the prevention, treatment, and diagnosis of diseases. The use of nanotechnology to optimize the delivery of drugs and diagnostic molecules is increasingly receiving attention due to the enhanced efficiency provided by these systems. Understanding the structures of nanocarriers is crucial in elucidating their physical and chemical properties, which greatly influence their behavior in the body at both the molecular and systemic levels. This review was conducted to describe the principles and characteristics of techniques commonly used to elucidate the structures of nanocarriers, with consideration of their size, morphology, surface charge, porosity, crystalline arrangement, and phase. These techniques include X-ray diffraction, small-angle X-ray scattering, dynamic light scattering, zeta potential, polarized light microscopy, transmission electron microscopy, scanning electron microcopy, and porosimetry. Moreover, we describe some of the commonly used nanocarriers (liquid crystals, metal-organic frameworks, silica nanospheres, liposomes, solid lipid nanoparticles, and micelles) and the main aspects of their structures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








![Figure 9 SAXS curves of the systems developed by Negrini et al,52 showing the reversibility of the mesophase following pH changes (pH 7 [lower curve] → pH 2 [middle curve] → pH 7 [upper curve]). Adapted with permission, from: Negrini R, Mezzenga R, pH-responsive lyotropic liquid crystals for controlled drug delivery. Langmuir 27(9), 2011, 5296–5303. Copyright 2017 American Chemical Society.52](https://figures.cochat.ai/paper-figures/096693895aa54288922b19e5981ebb0f/physicochemical-characterization-of-drug-nanocarriers-figure-9.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · cited 1×
“60 Finally, third-generation liposomes have been developed with targeting molecules (antibodies and peptides) on their surfaces in order to provide receptor recognition and active targeting of the drug.”
Horcajada, P., Chalati, T., Serre, C., Gillet, B., Sebrie, C., Baati, T., Eubank, J. F., Heurtaux, D., Clayette, P., Kreuz, C., et al. (2010) · Nature Materials · doi:10.1038/nmat2608 · Cited by 4,260 · cited 1×
“104 Compared with conventional porous materials, advantages of NMOFs include the ability to incorporate large amounts of drugs as well as their adjustable composition and structure.”
Transmission Electron Microscopy
Williams, D. B., & Carter, C. B. (2009) · Springer eBooks · doi:10.1007/978-0-387-76501-3 · Cited by 3,963 · cited 4×
“This is identical, in principle, to the more familiar medical computerized axial tomography (CAT) scans using X-rays.”
InfluentialDrug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848 · cited 1×
“87–89 More recently, discoveries based on inorganic nano-particles, such as mesoporous silica nanoparticles (MSNs), have opened up exciting new possibilities in this area.”
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759 · cited 1×
“4,65,67 Table 5 lists SLN formulations, the drugs or active ingredients used, and structural details obtained from DLS, zeta potential, and TEM/cryo-TEM analyses.”
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651 · cited 1×
“Introduction Recent years have seen increasing research interest in the development of new drug delivery systems that are based on nanoparticles with dimensions ranging from 1 to 1,000 nm.(1) Compared to conventional drug delivery systems, the use of nanoparticles for drug delivery offers advantages, including high st…”
BackgroundSolid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150 · cited 2×
“4,65,67 Table 5 lists SLN formulations, the drugs or active ingredients used, and structural details obtained from DLS, zeta potential, and TEM/cryo-TEM analyses.”
Metal–organic frameworks: a new class of porous materials
Rowsell, J. L. C., & Yaghi, O. M. (2004) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2004.03.034 · Cited by 2,963
Mesoporous Materials for Drug Delivery
Vallet‐Regí, M., Balas, F., & Arcos, D. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604488 · Cited by 2,507 · cited 3×
“85 The pore diameter can typically be altered in the range from 2 to 50 nm by changing the components of these materials, enabling the production of various mesoporous materials that are able to host small drug molecules or macromolecules.”
Influential
Cited by
Ghezzi, M., Pescina, S., Padula, C., Santi, P., Del Favero, E., Cantù, L., & Nicoli, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.031 · Cited by 1,135
Understanding ligand-protected noble metal nanoclusters at work
Matus, M. F., & Häkkinen, H. (2023) · Nature Reviews Materials · doi:10.1038/s41578-023-00537-1 · Cited by 356
Qi, J., Hu, X., Dong, X., Lu, Y., Lu, H., Zhao, W., & Wu, W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.009 · Cited by 292
Lipid-Based Antimicrobial Delivery-Systems for the Treatment of Bacterial Infections
Wang, D.-Y., van der Mei, H. C., Ren, Y., Busscher, H. J., & Shi, L. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00872 · Cited by 208
“Liposome suspensions are considered to be unstable when their zeta potential is between −30 and +30mV (Manaia et al., 2017).”
BackgroundAdvances in Lipid and Metal Nanoparticles for Antimicrobial Peptide Delivery
Makowski, M., Silva, Í. C., do Amaral, C. P., Gonçalves, S., & Santos, N. C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110588 · Cited by 162
“Different techniques are available, suitable for the peculiarities of each material [28].”
Method
Metadata
- Authors
- Berbel Manaia, E., Paiva Abuçafy, M., Chiari-Andréo, B. G., Lallo Silva, B., Oshiro-Júnior, J. A., & Chiavacci, L.
- Affiliations
- Universidade Estadual Paulista (Unesp) (BR)
- Corresponding author
- Chiavacci, Leila
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2017-07
- Volume
- Volume 12
- Pages
- 4991-5011
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC5516877
- OpenAlex
- W2734423857
- Cited by
- 207
- References
- 114
- Citations by year
- 2026: 21 · 2025: 28 · 2024: 25 · 2023: 30 · 2022: 29 · 2021: 21 · 2020: 22 · 2019: 17 · 2018: 14
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- UNESP Institutional Repository (São Paulo State University) (submittedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Universidade Estadual Paulista
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- drug nanocarriers, physicochemical characterization, surface charge, porosity, liquid crystals, metal-organic frameworks, silica nanospheres, liposomes, solid lipid nanoparticles, micelles, drug delivery
- MeSH terms
- Dynamic Light Scattering, Drug Carriers, Liposomes, Micelles, Microscopy, Silicon Dioxide, X-Ray Diffraction, Nanotechnology, Microscopy, Electron, Transmission, Nanostructures, Liquid Crystals, Nanoparticles, Scattering, Small Angle
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Physicochemical characterization of drug nanocarriers. https://app.cochat.ai/papers/10.2147/ijn.s133832
- The paper
- Berbel Manaia, E., Paiva Abuçafy, M., Chiari-Andréo, B. G., Lallo Silva, B., Oshiro-Júnior, J. A., & Chiavacci, L. (2017). Physicochemical characterization of drug nanocarriers. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s133832
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.